Pharmaceutical company AstraZeneca has launched its GCC Health Innovation Hub, a cornerstone of the company’s digital innovation efforts to facilitate diagnosis and treatment for diabetic patients, in conjunction with UK medtech start-up Gendius, which specialises in remote disease management
The company stated that as a result of this partnership, HealthGATE – an artificial intelligence (AI)-powered platform and app to support diabetic patient care in the GCC – will be launched later this year.
The HealthGATE app will act as a gateway between healthcare professionals and patients, enabling personalised care collaboration and the use of AI for better management of diseases.
Gendius CEO, Rory Cameron, said, “Diabetes is increasing health and economic burden across the Gulf region, but effective diabetes management has huge scope for reducing that burden. Our Intellin technology platform will be at the centre of this programme, and we are hugely excited to be bringing our innovative technology directly to GCC healthcare professionals and patients.”
Pelin Incesu, area vice-president, Middle East and Africa at AstraZeneca, said, “To accompany the implementation of HealthGATE, we will be expanding the EduGATE programme across all GCC countries by the second half of the year, establishing an innovative and sustainable model for enriching the region’s medical community – a crucial component of our strategy for establishing long-term partnerships. This is an exciting and essential next step that will allow the platform to develop further into a comprehensive healthcare ecosystem.”
EduGATE provides an accessible service for the sharing of patient materials, medical guidelines, live streaming events, online accreditation and more, creating an educational and enrichment experience for physicians across the country.
